Moneycontrol PRO
HomeNewsBusinessMarketsIPO market plunges 70% as higher rates, war curb risk appetite

IPO market plunges 70% as higher rates, war curb risk appetite

About $65 billion has been raised via IPOs around the world in 2022, down 70% from $219 billion in the first three months of last year.

March 27, 2022 / 10:28 IST
PC-Bloomberg

Initial public offerings worldwide have plummeted in the first quarter after a record showing in 2021, as volatility stoked by the war in Ukraine and soaring inflation sets investors on edge and scuppers deals.

About $65 billion has been raised via IPOs around the world in 2022, down 70% from $219 billion in the first three months of last year, according to data compiled by Bloomberg. That puts the global market on track for the lowest quarterly proceeds since the onset of the coronavirus pandemic in 2020.

Still, companies such as renewable-energy provider Plenitude and skin-care business Galderma are lining up to test investors’ appetite for new shares in the coming months.

ALSO READ: Nasdaq-listed Yatra Online’s Indian subsidiary files papers for an IPO

Stock market listings set a record in 2021 as unprecedented stimulus measures fueled a surge in global equities to all-time highs. Now, the backdrop couldn’t be more different, with central banks raising interest rates in response to mounting inflation and investors spooked by Russia’s invasion of Ukraine.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“This is probably the worst time in five years in terms of market sentiment,” said Li Hang, head of equity capital markets and syndicate at brokerage CLSA.

Rising interest rates combined with sharp market swings have prompted investors to steer clear of companies with high forecast growth rates yet relatively little in the way of current profits --- the kind of stocks that dominate the IPO market.

IPO Slump | PC-Bloomberg. IPO Slump | PC-Bloomberg.

“You need a more stable market to find the level at which IPOs can clear,” said Saadi Soudavar, Deutsche Bank AG’s co-head of equity capital markets for Europe, the Middle East and Africa.

The Cboe Volatility Index, a widely watched gauge of expected market swings, jumped above 30 when Russia invaded Ukraine and has had an average reading of about 26 this year, signaling IPOs might be too risky of an investment to receive sufficient appetite. Historically, a majority of global listings have been priced when the index has been below 25.

IPO market

Wild market swings have scuttled IPOs from New York to New Delhi. Life Insurance Corp., which planned to raise as much as 654 billion rupees ($8.5 billion) for the Indian government with an offering before the end of March, now is looking at a mid-May timeline. The offering would be one of the largest global listings this year.

Even quick-fire deals such as blank-check offerings, which are typically priced in a matter of days, are falling by the wayside. The vehicles, also known as special purpose acquisition companies, are shelving their listings at a record pace this year as investor enthusiasm wanes due to poor returns and heightened regulatory scrutiny.

Investment banks are starting to feel the effects: UBS Group AG began laying off a handful of bankers in equity capital markets in Europe, the Middle East and Africa this month, according to people familiar with the matter.

Bright Spots

It’s not all doom and gloom, however. While follow-on share sales start to pick up from Asia to Europe and the U.S., IPOs have been bucking the global trend and racing ahead in the Middle East, where high oil prices and rising interest rates are helping regional markets sharply outperform international ones.

“The Middle East is the one bright spot in an otherwise quiet global ECM market,” said Andree Chakhtoura, head of investment banking for the Middle East and North Africa at Bank of America Corp. “There is a wider and deeper market now than there has ever been before, and the offering is diversified.”

Many major commodities are trading at or near record levels, with the war in Ukraine raising supply concerns. This has already begun to spur capital markets activity.

Qatar’s sovereign wealth fund cashed in on a $1 billion stake in Glencore Plc via an overnight transaction March 23, while WE Soda, one of the world’s largest producers of natural soda ash, is evaluating options including a London IPO, Bloomberg News reported.

Strong Finish

Bankers continue to bet on a recovery in the second quarter, fueled in part by a full pipeline of large listing candidates readying to tap public investors, and the green shoots of a stock market rebound.

“A key question is when we can price the substantial pipeline of European IPOs waiting in the wings; we are hoping the answer is as early as May, June,” said Deutsche Bank’s Soudavar.

A number of high-profile listings from the likes of Thyssenkrupp AG’s Nucera and Italian green hydrogen specialist Industrie De Nora SpA are in the works in Europe. In the U.S., Rihanna’s Savage X Fenty lingerie company and SoftBank Group Corp.-backed chipmaker Arm Ltd. are among the big-ticket IPOs bankers are working on.

In Asia, private equity firm PAG and electric-vehicle maker Hozon New Energy Automobile Co. are in the pipeline with billion-dollar-plus offerings.

“The glass half-full view is that we could be in for a busy second quarter in equity capital markets,” said Andreas Bernstorff, BNP Paribas SA’s head of equity capital markets for Europe, Middle East and Africa. “Would expect to see block trades and equity-linked deals pick up first, and IPOs scheduled after Easter on the back of first-quarter numbers.”

Bloomberg
first published: Mar 26, 2022 04:19 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai